【结 构 式】 |
【分子编号】33694 【品名】cyclohexanecarbaldehyde 【CA登记号】2043-61-0 |
【 分 子 式 】C7H12O 【 分 子 量 】112.17168 【元素组成】C 74.95% H 10.78% O 14.26% |
合成路线1
该中间体在本合成路线中的序号:(IV)The acylation of 11beta,16alpha,17alpha,21-tetrahydroxypregna-1,4-diene-3,20-dione (I) with isobutyric anhydride in pyridine gives the 16,17,21-triester (III), which is condensed with cyclohexanecarbaldehyde (IV) by means of HCl and HClO4 in dioxane yielding the cyclic ketal (Va-b) as a diastereomeric mixture. Finally, this mixture is resolved by preparative HPLC over Lichrosorb RP-18 affording the desired (R)-isomer, the target compound. Alternatively, the monoacylation of the ketal 11beta,16alpha,17alpha,21-tetrahydroxypregan-1,4-diene-3,20-dione 16,17-O-cyclohexylmethylene ketal (VI) with isobutyric anhydride (II) by means of K2CO3 in acetone gives the previously described diastereomeric mixture (Va-b), which is resolved by crystallization in ethanol/water.
【1】 Calatayud, J.; Conde, J.R.; Luna, M. (Byk Elmu SA); Acetals and esters of 16alpha-hydroxyprednisolone and fluocinolone. BE 1005876; CH 683343; DE 4129535; ES 2034893; FR 2666585; GB 2247680; JP 1992257599; US 5482934 . |
【2】 Gutterer, B.; Amschler, H.; Flockerzi, D. (Byk Gulden Lomberg Chemische Fabrik GmbH); Process for R-epimer enrichment of 16,17-acetal derivs. of 21-acyloxy pregnan-1,4-dien-11beta,16alpha,17alpha-triol-3,20-dione derivs.. DE 19635498; WO 9809982 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(Va) | 38916 | 2-[(4aR,5S,6aS,8S,9aR)-8-cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6-yl]-2-oxoethyl 2-methylpropanoate | C32H44O7 | 详情 | 详情 | |
(Vb) | 38917 | 2-[(4aR,5S,6aS,8R,9aR)-8-cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6-yl]-2-oxoethyl 2-methylpropanoate | C32H44O7 | 详情 | 详情 | |
(I) | 32675 | (8S,9S,10R,11S,13S,14S,16R,17S)-17-glycoloyl-11,16,17-trihydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one | C21H28O6 | 详情 | 详情 | |
(II) | 22334 | 1-methylpropionic anhydride | 97-72-3 | C8H14O3 | 详情 | 详情 |
(III) | 38915 | 2-[(10R,11S,13S,16R,17S)-11-hydroxy-16,17-bis(isobutyryloxy)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl 2-methylpropanoate | C33H46O9 | 详情 | 详情 | |
(IV) | 33694 | cyclohexanecarbaldehyde | 2043-61-0 | C7H12O | 详情 | 详情 |
(VI) | 38918 | (4aR,5S,6aS,6bS,9aR)-8-cyclohexyl-6b-glycoloyl-5-hydroxy-4a,6a-dimethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one | C28H38O6 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(I)Treatment of cyclohexanecarboxaldehyde (I) with sulfur monochloride produced the dimeric disulfide (II). After condensation of (II) with 3-amino-1-propanol (III), reduction with NaBH4 afforded diamine (IV). Subsequent N-methylation of (IV) to give (VI) was achieved by condensation with formaldehyde, followed by NaBH4 reduction of the resulting oxazine (V). Reductive cleavage of the disulfide group of (VI) using LiAlH4 provided thiol (VII). Optionally, nitrosation of the sulfhydryl group of (VII) by means of tert-butyl nitrite gave rise to the nitrosothio derivative (VIII). Further coupling of this compound with diclofenac (IX) in the presence of DCC and DMAP furnished the title ester. Alternatively, the title compound was prepared by esterification of mercapto alcohol (VII) with diclofenac, followed by S-nitrosation of the resulting ester (X).
【1】 Bandarage, U.K.; et al.; Nitrosothiol esters of diclofonecac: Synthesis and pharmacological characterization as gastrointestinal-sparing prodrugs. J Med Chem 2000, 43, 21, 4005. |
【2】 Bandarage, U.K.; et al.; NMI-377, a nitric oxide-donating diclofenac derivative with gastroprotective properties. 217th ACS Natl Meet (March 21 1999, Anaheim) 1999, Abst MEDI 81. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 33694 | cyclohexanecarbaldehyde | 2043-61-0 | C7H12O | 详情 | 详情 |
(II) | 33695 | 1-[(1-formylcyclohexyl)disulfanyl]cyclohexanecarbaldehyde | C14H22O2S2 | 详情 | 详情 | |
(III) | 18522 | 3-amino-1-propanol | 156-87-6 | C3H9NO | 详情 | 详情 |
(IV) | 33696 | 3-[([1-[(1-[[(3-hydroxypropyl)amino]methyl]cyclohexyl)disulfanyl]cyclohexyl]methyl)amino]-1-propanol | C20H40N2O2S2 | 详情 | 详情 | |
(V) | 33697 | bis[1-(1,3-oxazinan-3-ylmethyl)cyclohexyl] disulfide; 3-[(1-[[1-(1,3-oxazinan-3-ylmethyl)cyclohexyl]disulfanyl]cyclohexyl)methyl]-1,3-oxazinane | C22H40N2O2S2 | 详情 | 详情 | |
(VI) | 33698 | 3-[([1-[(1-[[(3-hydroxypropyl)(methyl)amino]methyl]cyclohexyl)disulfanyl]cyclohexyl]methyl)(methyl)amino]-1-propanol | C22H44N2O2S2 | 详情 | 详情 | |
(VII) | 33699 | 3-[methyl[(1-sulfanylcyclohexyl)methyl]amino]-1-propanol | C11H23NOS | 详情 | 详情 | |
(VIII) | 33700 | 1-[[(3-hydroxypropyl)(methyl)amino]methyl]-N-oxocyclohexanesulfenamide | C11H22N2O2S | 详情 | 详情 | |
(IX) | 33701 | Diclofenac; 2-[2-(2,6-Dichloroanilino)phenyl]acetic acid | C14H11Cl2NO2 | 详情 | 详情 | |
(X) | 33702 | 3-[methyl[(1-sulfanylcyclohexyl)methyl]amino]propyl 2-[2-(2,6-dichloroanilino)phenyl]acetate | C25H32Cl2N2O2S | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(XI)Coupling between ethyl 3-aminopropionate (I) and N-Boc-glycine (II) by means of EDC and HOBt affords the protected dipeptide (III). After acidic Boc group cleavage in (III), the N-deprotected dipeptide (IV) is acylated by 3,3,3-triphenylpropionic acid (V) to produce amide (VI). Saponification of the ethyl ester group of (VI) yields acid (VII). This is coupled with (R)-1-Boc-3-(aminomethyl)piperidine (VIII) to afford amide (IX), which is further subjected to acidic N-Boc group cleavage. The resultant piperidine derivative (X) is then reductively condensed with cyclohexanecarboxaldehyde (XI) in the presence of NaBH(OAc)3 to furnish the title compound.
【1】 Kimura, T.; Noguchi, K.; Otake, N.; Uchiyama, M.; Naya, A.; Sagara, Y.; Numazawa, T.; Fujikawa, T. (Banyu Pharmaceutical Co., Ltd.); Novel amide derivs.. EP 1213281; WO 0107406 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 17639 | beta-Alanine, ethyl ester; ethyl 3-aminopropanoate | 924-73-2 | C5H11NO2 | 详情 | 详情 |
(II) | 18066 | N-alpha-t-BOC-glycine; 2-[(tert-butoxycarbonyl)amino]acetic acid | 4530-20-5 | C7H13NO4 | 详情 | 详情 |
(III) | 57638 | ethyl 3-({2-[(tert-butoxycarbonyl)amino]acetyl}amino)propanoate | C12H22N2O5 | 详情 | 详情 | |
(IV) | 57639 | ethyl 3-[(2-aminoacetyl)amino]propanoate | C7H14N2O3 | 详情 | 详情 | |
(V) | 57640 | 3,3,3-Triphenylpropionic acid; Tritylacetic acid | 900-91-4 | C21H18O2 | 详情 | 详情 |
(VI) | 57641 | ethyl 3-({2-[(3,3,3-triphenylpropanoyl)amino]acetyl}amino)propanoate | C28H30N2O4 | 详情 | 详情 | |
(VII) | 57642 | N-{2-[(3,3,3-triphenylpropanoyl)amino]acetyl}-beta-alanine | C26H26N2O4 | 详情 | 详情 | |
(VIII) | 57643 | tert-butyl (3R)-3-(aminomethyl)-1-piperidinecarboxylate | C11H22N2O2 | 详情 | 详情 | |
(IX) | 57644 | tert-butyl (3R)-3-({[3-({2-[(3,3,3-triphenylpropanoyl)amino]acetyl}amino)propanoyl]amino}methyl)-1-piperidinecarboxylate | C37H46N4O5 | 详情 | 详情 | |
(X) | 57645 | N-{2-oxo-2-[(3-oxo-3-{[(3S)piperidinylmethyl]amino}propyl)amino]ethyl}-3,3,3-triphenylpropanamide | C32H38N4O3 | 详情 | 详情 | |
(XI) | 33694 | cyclohexanecarbaldehyde | 2043-61-0 | C7H12O | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(XI)The primary amino group of 4-(aminomethyl)piperidine (I) was protected by conversion to the phthalimide (III) upon heating with phthalic anhydride (II). After coupling of piperidine (III) with 1-naphthylacetic acid (IV) to give amide (V), hydrazinolysis of the phthalimido group of (V) liberated the primary amine (VI). Alkylation of (VI) with N-(4-bromobutyl)phthalimide (VII) furnished the secondary amine (VIII), which was further protected with a tert-butoxycarbonyl group to provide (IX). The phthaloyl group of (IX) was then removed by hydrazinolysis, yielding amine (X). This was subjected to reductive alkylation with cyclohexanecarboxaldehyde (XI) in the presence of NaBH4 to afford the cyclohexylmethyl amine (XII). After purification as the di-Boc derivative, acid cleavage of the tert-butyl carbamate groups provided the title compound.
【1】 Yoneda, Y.; et al.; Synthesis of diaminobutane derivatives as potent Ca2+-permeable AMPA receptor antagonists. Bioorg Med Chem Lett 2001, 11, 19, 2663. |
【2】 Ito, M.; Yoneda, Y.; Kawagoe, K.; Yasukouchi, T.; Kito, F.; Mimura, T.; Kawajiri, S.; Sugimura, M.; Saito, M.; Tatematu, T.; Discovery of diaminobutane derivatives as Ca2+ -permeable AMPA receptor antagonists. Bioorg Med Chem 2002, 10, 5, 1347. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 19349 | 4-piperidinylmethylamine; 4-piperidinylmethanamine; 4-(Aminomethyl)piperidine | 7144-05-0 | C6H14N2 | 详情 | 详情 |
(II) | 11900 | 2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride | 85-44-9 | C8H4O3 | 详情 | 详情 |
(III) | 51132 | 2-(4-piperidinylmethyl)-1H-isoindole-1,3(2H)-dione | C14H16N2O2 | 详情 | 详情 | |
(IV) | 51133 | Planofix; alpha-Naphthylacetic acid; 1-Naphthaleneacetic acid; 1-Naphthylacetic acid; alpha-Naphthaleneacetic acid; Naphthalene-1-acetic acid | 86-87-3 | C12H10O2 | 详情 | 详情 |
(V) | 51134 | 2-([1-[2-(1-naphthyl)acetyl]-4-piperidinyl]methyl)-1H-isoindole-1,3(2H)-dione | C26H24N2O3 | 详情 | 详情 | |
(VI) | 51135 | 1-[4-(aminomethyl)-1-piperidinyl]-2-(1-naphthyl)-1-ethanone | C18H22N2O | 详情 | 详情 | |
(VII) | 17163 | N-(4-Bromobutyl)phthalimide; 2-(4-Bromobutyl)-1H-isoindole-1,3(2H)-dione | 5394-18-3 | C12H12BrNO2 | 详情 | 详情 |
(VIII) | 51136 | 2-[4-[([1-[2-(1-naphthyl)acetyl]-4-piperidinyl]methyl)amino]butyl]-1H-isoindole-1,3(2H)-dione | C30H33N3O3 | 详情 | 详情 | |
(IX) | 51137 | tert-butyl 4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)butyl([1-[2-(1-naphthyl)acetyl]-4-piperidinyl]methyl)carbamate | C35H41N3O5 | 详情 | 详情 | |
(X) | 51138 | tert-butyl 4-aminobutyl([1-[2-(1-naphthyl)acetyl]-4-piperidinyl]methyl)carbamate | C27H39N3O3 | 详情 | 详情 | |
(XI) | 33694 | cyclohexanecarbaldehyde | 2043-61-0 | C7H12O | 详情 | 详情 |
(XII) | 51139 | tert-butyl 4-[(cyclohexylmethyl)amino]butyl([1-[2-(1-naphthyl)acetyl]-4-piperidinyl]methyl)carbamate | C34H51N3O3 | 详情 | 详情 |
合成路线5
该中间体在本合成路线中的序号:(VII)Saponification of ethyl adamantyloxyacetate (I), followed by treatment of the resultant carboxylic acid (II) with oxalyl chloride gives rise to acid chloride (III). This is then condensed with benzyl (triphenylphosphoranylidene)acetate (IV) to produce the phosphoranylidene keto ester (V). Subsequent oxidative cleavage of phosphorane (V) with oxone under phase transfer conditions leads to diketo ester (VI). Cyclization between diketo ester (VI), cyclohexanecarboxaldehyde (VII) and ammonium acetate in hot AcOH affords imidazole (VIII). The benzyl ester group of (VIII) is removed by catalytic hydrogenolysis, yielding acid (IX), which is further coupled with benzyl 3-aminobenzoate (X) to furnish amide (XI). Finally, benzyl ester hydrogenolysis in the presence of Pd/C provides the target compound (1,2).
【1】 Gastrin and cholecystokinin receptor ligands. JP 2002529455; US 6479531; WO 0027823 . |
【2】 Kalindjian, S.B.; Mesens, J.L.; Black, J.W.; Hull, R.A.D.; Shankley, N.P.; Andries, L.J. (James Black Foundation Ltd.; Janssen Pharmaceutica NV); Pharmaceutical compsns. comprising proton pump inhibitors and gastrin/cholecystokinin receptor ligands. WO 0185167 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 64427 | ethyl 2-(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)acetate | C14H22O3 | 详情 | 详情 | |
(II) | 64428 | 2-(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)acetic acid | C12H18O3 | 详情 | 详情 | |
(III) | 64429 | 2-(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)acetyl chloride | C12H17ClO2 | 详情 | 详情 | |
(IV) | 22668 | benzyl 2-(triphenylphosphoranylidene)acetate | C27H23O2P | 详情 | 详情 | |
(V) | 64430 | phenylmethyl 3-oxo-4-(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)-2-(triphenyl-lambda~5~-phosphanylidene)butanoate | C39H39O4P | 详情 | 详情 | |
(VI) | 64449 | phenylmethyl 2,3-dioxo-4-(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)butanoate | C21H24O5 | 详情 | 详情 | |
(VII) | 33694 | cyclohexanecarbaldehyde | 2043-61-0 | C7H12O | 详情 | 详情 |
(VIII) | 64450 | phenylmethyl 2-cyclohexyl-5-[(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)methyl]-1H-imidazole-4-carboxylate | C28H36N2O3 | 详情 | 详情 | |
(IX) | 64461 | 2-cyclohexyl-5-[(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)methyl]-1H-imidazole-4-carboxylic acid | C21H30N2O3 | 详情 | 详情 | |
(X) | 64462 | phenylmethyl 3-aminobenzoate | C14H13NO2 | 详情 | 详情 | |
(XI) | 64463 | phenylmethyl 3-[({2-cyclohexyl-5-[(tricyclo[3.3.1.1~3,7~]dec-1-yloxy)methyl]-1H-imidazol-4-yl}carbonyl)amino]benzoate | C35H41N3O4 | 详情 | 详情 |
合成路线6
该中间体在本合成路线中的序号:(II)
【1】 彭璃螭,赣开智.2004.一种哮啮治疗药物环索奈德的新的制备方法,发明专7f4V开说明书,CN1626546A |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 66189 | 2-((6aS,7R,8aR,8bR)-7-hydroxy-6a,8a,10,11a-tetramethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl isobutyrate | C28H38O7 | 详情 | 详情 | |
(II) | 33694 | cyclohexanecarbaldehyde | 2043-61-0 | C7H12O | 详情 | 详情 |
(III) | 38917 | 2-[(4aR,5S,6aS,8R,9aR)-8-cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6-yl]-2-oxoethyl 2-methylpropanoate | C32H44O7 | 详情 | 详情 |
合成路线7
该中间体在本合成路线中的序号:(IV)
【1】 Pierluigi R,MacDonald P.2007.Improved process for the preparation of ciclesonide. W0 2007056181 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 22334 | 1-methylpropionic anhydride | 97-72-3 | C8H14O3 | 详情 | 详情 |
(II) | 66190 | (6aS,7R,8aR,8bR,11aS,12bR)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10,10-tetramethyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one | C24H32O6 | 详情 | 详情 | |
(III) | 66191 | (6aR,7S,8aS,8bS,11aR,12bS)-7-hydroxy-8b-isobutyryl-6a,8a,10,10-tetramethyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one | C26H36O5 | 详情 | 详情 | |
(IV) | 38916 | 2-[(4aR,5S,6aS,8S,9aR)-8-cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6-yl]-2-oxoethyl 2-methylpropanoate | C32H44O7 | 详情 | 详情 | |
(IV) | 33694 | cyclohexanecarbaldehyde | 2043-61-0 | C7H12O | 详情 | 详情 |